LCGC North America
Here, we concentrate on one particularly useful equation that allows us to make changes to an analytical system to improve throughput or efficiency, while retaining the selectivity of the original method.
Several mathematical relationships are useful in gradient elution reversed-phase liquid chromatography (LC), and the webcast and tutorial from which this excerpt is taken describes many of them. Here, we concentrate on one particularly useful equation that allows us to make changes to an analytical system to improve throughput or efficiency, while retaining the selectivity of the original method. This equation can be particularly useful when developing or translating high performance liquid chromatography (HPLC) methods.
Equation 1 defines a corrected measure of gradient steepness (1) and measures the change in modifier concentration (%B) per column volume of mobile phase:
where F is eluent flow rate (in milliliters per minute), tG is the gradient time (in minutes), ΔΦ is the percent change in organic modifier over the gradient (5–95% B would be represented as 90), and Vm represents the interstitial volume (that is, the volume of mobile phase) within the column and can be simply calculated using equation 2:
where r is the column radius (in millimeters), L is the column length (also in millimeters), W is the column percent interstitial porosity, W (fully porous materials) ≈ 68% (0.68), and W (core-shell particles) ≈ 55% (0.55). So, for a method using a 150 mm × 4.6 mm column with 5-µm fully porous silica and a gradient of 20–60% B over 30 min at a flow rate of 1 mL/min, the value of Gs would be calculated as follows:
Vm = π × 2.32 × 150 × 0.68 = 1695 (mL) = 1.7 mL
Gs = 1.7 × 40/1 × 30
Gs = 2.27 %B/column volume
Figure 1a shows the initial chromatogram with a very long run time and poor signal to noise for the diffuse (broad) later eluted peaks. We can speed up this method and hopefully retain good selectivity and resolution in the simplest way by doubling the flow rate; however, to keep the gradient steepness constant then we could, for example, halve the gradient time (tG) (F = 2 and tG = 15) (Figure 1b).
Another very convenient way to speed up the separation is to double the gradient range (ΔΦ = 80), which would mean using a gradient range of 20–100% B. This can also be compensated to keep Gs constant by doubling the flow rate (F = 2)-the result of which is shown in Figure 1c.
When translating to smaller column dimensions, we also have a range of choices to keep the adjusted gradient steepness constant. Here we switch to a 100 mm × 2.1 mm, 2.7-µm superficially porous particle column with a Vm of 0.19 mL. We used a low-dead-volume ultrahigh-pressure liquid chromatography (UHPLC) system to rapidly mix a 20–80% B gradient in 10 min with a flow rate of 0.5 mL/min.
Gs = 0.19 × 60/0.5 × 10
Vm = 0.19, ΔΦ =60, F = 0.5 mL/min, tG = 10 min
Gs = 2.28
Using the corrected gradient steepness (Gs), which allows us to maintain the %B per column volume rate of change, we were able to achieve a sixfold reduction in analysis time without compromising the quality of the separation as measured by the minimum resolution of any peak pair.
Reference
(1) L.R. Snyder, J.J. Kirkland, and J.L. Glajch, Practical HPLC Method Development (Wiley, New York, 1997).
Get the full tutorial at www.CHROMacademy.com/Essentials (free until August 20).
RAFA 2024 Highlights: Contemporary Food Contamination Analysis Using Chromatography
November 18th 2024A series of lectures focusing on emerging analytical techniques used to analyse food contamination took place on Wednesday 6 November 2024 at RAFA 2024 in Prague, Czech Republic. The session included new approaches for analysing per- and polyfluoroalkyl substances (PFAS), polychlorinated alkanes (PCAS), Mineral Oil Hydrocarbons (MOH), and short- and medium-chain chlorinated paraffins (SCCPs and MCCPs).
Advancing Bladder Cancer Research with Mass Spectrometry: A FeMS Interview with Marta Relvas-Santos
November 12th 2024LCGC International interviewed FeMS Empowerment Award winner Marta Relvas-Santos on her use of mass spectrometry to identify potential biomarkers and therapies for bladder cancer. She also shared insights on her work with FeMS and advice for fellow scientists.